Seeking Alpha

Johnson & Johnson (JNJ) is raised to Buy from Hold with an $82 price target, up from...

Johnson & Johnson (JNJ) is raised to Buy from Hold with an $82 price target, up from $75, at Deutsche Bank, which cites improving sales trends and benefits of diversification. Recent and new drugs should continue to drive pharma sales, and JNJ should continue to work through the McNeil Consent Decree and return consumer products to market. JNJ +0.6% premarket.
Comments (1)
  • tampabay
    , contributor
    Comments (301) | Send Message
     
    Send Email to Warren
    4 Jan 2013, 11:07 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector